DSP Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • 0.99 %Nav, as on 24-07-2025

  • Previous Nav

  • Net Change on 24-07-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
DSP Healthcare Fund - Regular Plan - Growth 6.94 6.73 12.62 25.95 22.65 23.44
BSE Health Care - TRI N/A N/A N/A N/A N/A N/A
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
DSP Healthcare Fund - Regular Plan - Growth Nov 30, 2018 12.62 25.95 22.65 1.93 3,056.90
Nippon India Pharma Fund-Growth Plan-Growth Jun 05, 2004 12.08 24.58 21.81 1.80 8,569.15
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 18.41 29.06 24.19 1.89 5,727.59
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH Jul 14, 1999 19.80 28.39 23.89 1.93 3,849.24
Mirae Asset Healthcare Fund -Regular Growth Jul 02, 2018 13.80 23.31 21.71 1.93 2,785.12
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 11.30 24.02 21.77 2.11 1,281.99

Fund Holdings as on 30-June-2025

  • Cipla Limited

  • Sun Pharmaceutical Industries Limited

  • Cohance Lifesciences Limited

  • IPCA Laboratories Limited

  • Gland Pharma Limited

  • Laurus Labs Limited

  • Alembic Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • Globus Medical Inc

  • Sai Life Sciences Limited

  • Illumina Inc

  • Pfizer Limited

  • Indoco Remedies Limited

  • Kovai Medical Center and Hospital Limited

  • Procter & Gamble Health Limited

  • Vijaya Diagnostic Centre Limited

  • Concord Biotech Limited

  • Intuitive Surgical Inc

  • TREPS / Reverse Repo Investments

  • Unichem Laboratories Limited

  • ICICI Lombard General Insurance Company Limited

  • Emcure Pharmaceuticals Limited

  • Aarti Drugs Limited

  • Abbott Laboratories

  • Thyrocare Technologies Limited

  • Alkem Laboratories Limited

  • Global X Funds - Global X Genomics & Biotechnology ETF

  • Medplus Health Services Limited

  • Jupiter Life Line Hospitals Limited

  • Laxmi Dental Limited

  • Grail Inc

  • Net Receivables/Payables

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Hospital & Healthcare Services

  • Insurance

  • Medical Equipment/Supplies/Accessories

View More

Fund Manager

  • Cash

  • Equity

  • MFU

View More

About DSP Healthcare Fund

Scheme Analysis

DSP Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to DSP Mutual Fund. It was launched on 30-Nov-2018 and currently has an AUM of ₹3,056.90 crore. DSP Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.

The NAV of DSP Healthcare Fund ended up ₹0.4(0.99%)yesterday to ₹40.581.

Among its top 3 holdings the fund has exposure to Cipla Limited, and

The DSP Healthcare Fund is managed by Chirag Dagli .

Fund House Contact

The Ruby, 25th Floor, 29, Senapati Bapat Marg, Dadar (West) Mumbai - 400 028

+91 (22) 66578000
service@dspim.com
+91 (22) 66578181